title: [Bacterial vaginosis. Treatment of the relapse].
abstract: Bacterial vaginosis (BV) is a common vaginal infection in women of reproductive age. Bacterial vaginosis is an ecological disorder that ensues when normal lactobacilli are replaced by large numbers of Gardnerella vaginalis, Prevotella sp., Bacteroides sp., Mobiluncus sp. and M. hominis. Numerous studies have consistently shown that BV at 12-24 weeks are associated with increased risks of preterm birth (PTB), preterm rupture of the membranes, chorioamnionitis, fetal infection and cerebral palsy. Deficiencies in local immunity may predispose women to BV.
authors.forename: M
authors.initials: M
authors.lastname: Malinova
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000382:microbiology / Q000517:prevention & control*; D019936:Probiotics / Q000627:therapeutic use*; D055502:Secondary Prevention; D014621:Vagina / Q000187:drug effects / Q000382:microbiology*; D016585:Vaginosis, Bacterial / Q000150:complications / Q000382:microbiology / Q000517:prevention & control*; D047071:beta-Glucans / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D047071:beta-Glucans